How to Make Your Case to Attend Breakthrough 2025: AI in Action
Are you eager to attend Breakthrough 2025 this March in Zurich but need to secure approval from your manager or team?
Extracting tangible value from AI in Regulatory Affairs, Compliance & More
In anticipation of a rousing Breakthrough 2025, Regulatory consultant and panel session moderator Preeya Beczek sets out her hopes for this year’s event.
Taking the pulse: how ready is the Regulatory function for AI-enabled reinvention?
Steve Gens previews some of the new research findings he’ll come armed with to a discussion panel on the future of Regulatory operations in an AI automation context.Â
5 Reasons You Can’t Miss Breakthrough 2025
Breakthrough 2025 is set to be a pivotal event for safety, regulatory, and life sciences professionals.
What to Expect and What’s Trending in Regulatory Affairs
In the rapidly evolving landscape of regulatory affairs, significant advancements and trends are shaping the future. At ArisGlobal, we're committed to staying at the forefront of these changes and ensuring our clients are well-prepared. Here's a deep dive into the latest developments and what to expect in the coming years.Â
6 Ways to Discover Greater Value from Your Safety Platform
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Employing Generative AI to Drive Connected Regulatory Intelligence
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Delivering Tangible GenAI Use Cases in Regulatory: Accelerated Health Authority Interactions
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
How One Global Pharma Navigated Change Management to Leverage Automation and AI
In the ever-evolving pharmacovigilance landscape , embracing automation and AI has become a strategic necessity for global pharmaceutical companies.
Transforming Pharmacovigilance: Advanced Automation Use Cases
A reported 86% of pharmaceutical companies plan to significantly increase their investment in automation technologies over the next five years.
